Document Detail


Regulation of adverse remodelling by osteopontin in a genetic heart failure model.
MedLine Citation:
PMID:  21525025     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Aims Desmin, the muscle-specific intermediate filament protein, is a major target in dilated cardiomyopathy and heart failure in humans and mice. The hallmarks of desmin-deficient (des(-/-)) mice pathology include pronounced myocardial degeneration, extended fibrosis, and osteopontin (OPN) overexpression. We sought to identify the molecular and cellular events regulating adverse cardiac remodelling in des(-/-) mice and their potential link to OPN. Methods and results In situ hybridization, histology, and immunostaining demonstrated that inflammatory cells and not cardiomyocytes were the source of OPN. RNA profile comparison revealed that activation of inflammatory pathways, sustained by innate immunity mechanisms, predominated among all changes occurring in degenerating des(-/-) myocardium. The expression of the most highly up-regulated genes (OPN: 226×, galectin-3: 26×, osteoactivin/Gpnmb/DC-HIL: 160× and metalloprotease-12: 98×) was associated with heart infiltrating macrophages. To evaluate the role of OPN, we generated des(-/-)OPN(-/-) mice and compared their cardiac function and remodelling indices with those of des(-/-). Osteopontin promoted cardiac dysfunction in this model since des(-/-)OPN(-/-) mice showed 53% improvement of left ventricular function, paralleled to an up to 44% reduction in fibrosis. The diminished fibrotic response in the absence of OPN could be partly mediated by a dramatic reduction in myocardial galectin-3 levels, associated with an impaired galectin-3 secretion by OPN-deficient infiltrating macrophages. Conclusion Cardiomyocyte death due to desmin deficiency leads to inflammation and subsequent overexpression of a series of remodelling modulators. Among them, OPN seems to be a major regulator of des(-/-) adverse myocardial remodelling and it functions at least by potentiating galectin-3 up-regulation and secretion.
Authors:
Stelios Psarras; Manolis Mavroidis; Despina Sanoudou; Constantinos H Davos; Georgina Xanthou; Aimilia E Varela; Vily Panoutsakopoulou; Yassemi Capetanaki
Related Documents :
9307445 - Single versus bilateral internal mammary artery grafts: 10-year outcome analysis.
21804195 - Recent advances in the molecular pathophysiology of atrial fibrillation.
17307455 - Intraoperative transesophageal echocardiography modifies strategy in off-pump coronary ...
8776185 - Heparin-coated circuit in coronary surgery. a clinical study.
22427775 - Hemodynamic support with tandemheart in tako-tsubo cardiomyopathy - a case report.
11792225 - St-segment elevation myocardial infarction.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-4-26
Journal Detail:
Title:  European heart journal     Volume:  -     ISSN:  1522-9645     ISO Abbreviation:  -     Publication Date:  2011 Apr 
Date Detail:
Created Date:  2011-4-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8006263     Medline TA:  Eur Heart J     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Cell Biology Division, Center of Basic Research I, Biomedical Research Foundation, Academy of Athens (BRFAA), Soranou Efessiou 4, Athens 11527, Greece.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Relevance of vancomycin-intermediate susceptibility and heteroresistance in methicillin-resistant St...
Next Document:  Effects of reclassification from the TNM-6 into the TNM-7 staging system in bronchoplastic resection...